Anti-Human CD4 Recombinant Antibody(Priliximab)
-
产品编号
YR1098
-
别名
科研级 Priliximab ( 普立昔单抗 ), Anti-CD4 Recombinant Antibody, Research Grade Priliximab
-
规格
- 1mg
- 5mg
Alias | 科研级 Priliximab ( 普立昔单抗 ), Anti-CD4 Recombinant Antibody, Research Grade Priliximab |
Catalog Number | YR1098 |
Molecular Name | Priliximab |
Size | 1mg, 5mg |
Clonity | Monoclonal |
Purity | >95% as determined by SDS-PAGE |
Concentration | 1mg/ml |
Antibody Isotype | IgG1 Kappa |
Formulation | PBS, pH7.5 |
Background | Priliximab (cMT 412) is a human-mouse chimeric anti-CD4 monoclonal antibody. It has been tested on patients with Crohn's disease and multiple sclerosis but has not yet received U.S. Food and Drug Administration licensing. The patent belongs to the biotechnology company Centocor. |
Storage Condition | It is recommended to aliquote and store at -20°C for long term storage. Avoid repeated freezing and thawing cycles. |
Remarks | This product is for research use only. |
Shipping Condition | Shipped on ice packs. |
Target | CD4[Homo sapiens] |